These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 16158078)
1. Hypertriglyceridemia as a possible risk factor for prostate cancer. Wuermli L; Joerger M; Henz S; Schmid HP; Riesen WF; Thomas G; Krek W; Cerny T; Gillessen S Prostate Cancer Prostatic Dis; 2005; 8(4):316-20. PubMed ID: 16158078 [TBL] [Abstract][Full Text] [Related]
2. The impact of hypertriglyceridemia on prostate cancer development in patients aged ≥60 years. Hayashi N; Matsushima M; Yamamoto T; Sasaki H; Takahashi H; Egawa S BJU Int; 2012 Feb; 109(4):515-9. PubMed ID: 21812901 [TBL] [Abstract][Full Text] [Related]
3. Hyperinsulinaemia: a prospective risk factor for lethal clinical prostate cancer. Hammarsten J; Högstedt B Eur J Cancer; 2005 Dec; 41(18):2887-95. PubMed ID: 16243513 [TBL] [Abstract][Full Text] [Related]
4. Obesity, adipokines, and prostate cancer in a prospective population-based study. Baillargeon J; Platz EA; Rose DP; Pollock BH; Ankerst DP; Haffner S; Higgins B; Lokshin A; Troyer D; Hernandez J; Lynch S; Leach RJ; Thompson IM Cancer Epidemiol Biomarkers Prev; 2006 Jul; 15(7):1331-5. PubMed ID: 16835332 [TBL] [Abstract][Full Text] [Related]
6. Indicators of sexual and somatic development and adolescent body size in relation to prostate cancer risk: results from a case-control study. Barba M; Terrenato I; Schünemann HJ; Fuhrman B; Sperati F; Teter B; Gallucci M; D'Amato A; Muti P Urology; 2008 Jul; 72(1):183-7. PubMed ID: 18280559 [TBL] [Abstract][Full Text] [Related]
7. Evaluating body composition of Italian prostate cancer patients without metastases. Maturo G; Vespasiani G; Mohamed EI; Maiolo C; Finazzi Agrò E; Forte F; De Lorenzo A Acta Diabetol; 2003 Oct; 40 Suppl 1():S168-70. PubMed ID: 14618463 [TBL] [Abstract][Full Text] [Related]
8. Cholesterol-lowering drugs and prostate cancer risk: a population-based case-control study. Murtola TJ; Tammela TL; Lahtela J; Auvinen A Cancer Epidemiol Biomarkers Prev; 2007 Nov; 16(11):2226-32. PubMed ID: 18006910 [TBL] [Abstract][Full Text] [Related]
9. Prostate-specific antigen/prostatic acid phosphatase ratio is significant prognostic factor in patients with stage IV prostate cancer. Saito T; Hara N; Kitamura Y; Komatsubara S Urology; 2007 Oct; 70(4):702-5. PubMed ID: 17991541 [TBL] [Abstract][Full Text] [Related]
10. Hormonal predictors of prostate cancer. Sofikerim M; Eskicorapci S; Oruç O; Ozen H Urol Int; 2007; 79(1):13-8. PubMed ID: 17627161 [TBL] [Abstract][Full Text] [Related]
11. Patterns of lipid changes among type 2 diabetes patients in Sudan. Elnasri HA; Ahmed AM East Mediterr Health J; 2008; 14(2):314-24. PubMed ID: 18561723 [TBL] [Abstract][Full Text] [Related]
12. Influence of anthropometric measurements, age, and prostate volume on prostate-specific antigen levels in men with a low risk of prostate cancer. Ochiai A; Fritsche HA; Babaian RJ Urology; 2005 Oct; 66(4):819-23. PubMed ID: 16230145 [TBL] [Abstract][Full Text] [Related]
13. Corneal arcus and hyperlipidemia: findings from an older population. Chua BE; Mitchell P; Wang JJ; Rochtchina E Am J Ophthalmol; 2004 Feb; 137(2):363-5. PubMed ID: 14962437 [TBL] [Abstract][Full Text] [Related]
14. Lymphovascular invasion is an independent prognostic factor in prostatic adenocarcinoma. Cheng L; Jones TD; Lin H; Eble JN; Zeng G; Carr MD; Koch MO J Urol; 2005 Dec; 174(6):2181-5. PubMed ID: 16280760 [TBL] [Abstract][Full Text] [Related]
15. Association of body mass index with response and survival in men with metastatic prostate cancer: Southwest Oncology Group trials 8894 and 9916. Montgomery RB; Goldman B; Tangen CM; Hussain M; Petrylak DP; Page S; Klein EA; Crawford ED; J Urol; 2007 Nov; 178(5):1946-51; discussion 1951. PubMed ID: 17868721 [TBL] [Abstract][Full Text] [Related]
16. Obesity, diabetes, and risk of prostate cancer: results from the prostate cancer prevention trial. Gong Z; Neuhouser ML; Goodman PJ; Albanes D; Chi C; Hsing AW; Lippman SM; Platz EA; Pollak MN; Thompson IM; Kristal AR Cancer Epidemiol Biomarkers Prev; 2006 Oct; 15(10):1977-83. PubMed ID: 17035408 [TBL] [Abstract][Full Text] [Related]
17. Association of obesity, serum glucose and lipids with the risk of advanced colorectal adenoma and cancer: a case-control study in Korea. Chung YW; Han DS; Park YK; Son BK; Paik CH; Lee HL; Jeon YC; Sohn JH Dig Liver Dis; 2006 Sep; 38(9):668-72. PubMed ID: 16790371 [TBL] [Abstract][Full Text] [Related]
18. Anthropometrics and prostate cancer risk. Littman AJ; White E; Kristal AR Am J Epidemiol; 2007 Jun; 165(11):1271-9. PubMed ID: 17395597 [TBL] [Abstract][Full Text] [Related]
19. Lactase persistence, dietary intake of milk, and the risk for prostate cancer in Sweden and Finland. Torniainen S; Hedelin M; Autio V; Rasinperä H; Bälter KA; Klint A; Bellocco R; Wiklund F; Stattin P; Ikonen T; Tammela TL; Schleutker J; Grönberg H; Järvelä I Cancer Epidemiol Biomarkers Prev; 2007 May; 16(5):956-61. PubMed ID: 17507622 [TBL] [Abstract][Full Text] [Related]
20. [Prediction of the stage of patients with prostate cancer by the combination of serum prostate specific antigen and Gleason score]. Song G; Zhou LQ; He ZS; Li NC; Li M; Hao JR; Pan BN; Na YQ Zhonghua Wai Ke Za Zhi; 2006 Mar; 44(6):376-8. PubMed ID: 16638345 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]